New studies on retatruded, a dual activator for GLP-1 and glucose-dependent insulinotropic polypeptide, indicate significant results in treating weight gain and type 2 diabetic condition. Initial data from clinical assessments reveal considerable decreases in body weight and enhanced glucose regulation. Further research is focused on long-term h… Read More